Consensus Middle East and North Africa Registry on Inborn Errors of Immunity
- PMID: 34052995
- PMCID: PMC8310844
- DOI: 10.1007/s10875-021-01053-z
Consensus Middle East and North Africa Registry on Inborn Errors of Immunity
Abstract
Background: Inborn errors of immunity (IEIs) are a heterogeneous group of genetic defects of immunity, which cause high rates of morbidity and mortality mainly among children due to infectious and non-infectious complications. The IEI burden has been critically underestimated in countries from middle- and low-income regions and the majority of patients with IEI in these regions lack a molecular diagnosis.
Methods: We analyzed the clinical, immunologic, and genetic data of IEI patients from 22 countries in the Middle East and North Africa (MENA) region. The data was collected from national registries and diverse databases such as the Asian Pacific Society for Immunodeficiencies (APSID) registry, African Society for Immunodeficiencies (ASID) registry, Jeffrey Modell Foundation (JMF) registry, J Project centers, and International Consortium on Immune Deficiency (ICID) centers.
Results: We identified 17,120 patients with IEI, among which females represented 39.4%. Parental consanguinity was present in 60.5% of cases and 27.3% of the patients were from families with a confirmed previous family history of IEI. The median age of patients at the onset of disease was 36 months and the median delay in diagnosis was 41 months. The rate of registered IEI patients ranges between 0.02 and 7.58 per 100,000 population, and the lowest rates were in countries with the highest rates of disability-adjusted life years (DALY) and death rates for children. Predominantly antibody deficiencies were the most frequent IEI entities diagnosed in 41.2% of the cohort. Among 5871 patients genetically evaluated, the diagnostic yield was 83% with the majority (65.2%) having autosomal recessive defects. The mortality rate was the highest in patients with non-syndromic combined immunodeficiency (51.7%, median age: 3.5 years) and particularly in patients with mutations in specific genes associated with this phenotype (RFXANK, RAG1, and IL2RG).
Conclusions: This comprehensive registry highlights the importance of a detailed investigation of IEI patients in the MENA region. The high yield of genetic diagnosis of IEI in this region has important implications for prevention, prognosis, treatment, and resource allocation.
Keywords: Burden of disease; Epidemiology; Inborn errors of immunity; Molecular diagnosis; Primary immunodeficiency.
© 2021. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity.J Allergy Clin Immunol Pract. 2023 Jan;11(1):158-180.e11. doi: 10.1016/j.jaip.2022.10.003. Epub 2022 Oct 17. J Allergy Clin Immunol Pract. 2023. PMID: 36265766 Review.
-
A Prospective Survey of Skin Manifestations in Children With Inborn Errors of Immunity From a National Registry Over 17 Years.Front Immunol. 2021 Sep 30;12:751469. doi: 10.3389/fimmu.2021.751469. eCollection 2021. Front Immunol. 2021. PMID: 34659256 Free PMC article.
-
Inborn Errors of Immunity in Algerian Children and Adults: A Single-Center Experience Over a Period of 13 Years (2008-2021).Front Immunol. 2022 Apr 21;13:900091. doi: 10.3389/fimmu.2022.900091. eCollection 2022. Front Immunol. 2022. PMID: 35529857 Free PMC article.
-
The Spectrum of Inborn Errors of Immunity in the United Arab Emirates: 5 Year Experience in a Tertiary Center.Front Immunol. 2022 Jan 31;13:837243. doi: 10.3389/fimmu.2022.837243. eCollection 2022. Front Immunol. 2022. PMID: 35173743 Free PMC article.
-
Genetics of Inborn Errors of Immunity in highly consanguineous Middle Eastern and North African populations.Semin Immunol. 2023 May;67:101763. doi: 10.1016/j.smim.2023.101763. Epub 2023 Apr 17. Semin Immunol. 2023. PMID: 37075586 Review.
Cited by
-
Chronic granulomatous disease in the United Arab Emirates: clinical and molecular characteristics in a single center.Front Immunol. 2023 Nov 2;14:1228161. doi: 10.3389/fimmu.2023.1228161. eCollection 2023. Front Immunol. 2023. PMID: 38022624 Free PMC article.
-
Challenges of Diagnosing Mendelian Susceptibility to Mycobacterial Diseases in South Africa.Int J Mol Sci. 2023 Jul 28;24(15):12119. doi: 10.3390/ijms241512119. Int J Mol Sci. 2023. PMID: 37569495 Free PMC article. Review.
-
Inborn Errors of Immunity-the Sri Lankan Experience 2010-2022.J Clin Immunol. 2023 Nov;43(8):1858-1872. doi: 10.1007/s10875-023-01542-3. Epub 2023 Jul 22. J Clin Immunol. 2023. PMID: 37480474
-
Genetically confirmed chronic granulomatous disease in a Kenyan child: case report.Front Immunol. 2023 May 18;14:1172848. doi: 10.3389/fimmu.2023.1172848. eCollection 2023. Front Immunol. 2023. PMID: 37275907 Free PMC article.
-
Autoimmune versus Non-autoimmune Cutaneous Features in Monogenic Patients with Inborn Errors of Immunity.Biology (Basel). 2023 Apr 24;12(5):644. doi: 10.3390/biology12050644. Biology (Basel). 2023. PMID: 37237458 Free PMC article.
References
-
- Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J et al. The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol: In Practice. 2019;7(6):1763–70. - PubMed
-
- Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40(1):24–64. doi: 10.1007/s10875-019-00737-x. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
